Price of Apelis after medical insurance

Apelix is an innovative drug targeting malignant tumors, especially for the treatment of hormone receptor-positive, human epidermal growth factor receptor2-negative advanced or metastatic breast cancer with PIK3CA gene mutations. This drug is approved by the US FDA and recommended by NCCN guidelines for use in combination with fulvestrant as the first-choice second-line drug for breast cancer.

Clinical studies have shown that treatment with apelvis combined with fulvestrant can significantly extend the progression-free survival of patients, indicating that it has a better anti-tumor effect and can reduce the risk of disease progression. In addition to breast cancer, Apelvis has also shown certain efficacy in the treatment of other malignant tumors such as cervical cancer and colon cancer.

However, the use of Apelvis may also be associated with a series of side effects, such as hyperglycemia, nausea, vomiting, diarrhea, etc., which require close monitoring and timely adjustment of the treatment plan. At the same time, the use of Apelvis should be avoided for certain groups of people, such as pregnant women, women planning pregnancy, and patients with severe allergic reactions.

In addition, the recommended dose of apelvis is 300 mg dailytaken with food, and treatment should be continued until disease progression or unacceptable toxicity occurs. Patients should follow the doctor's instructions during medication and take the medication on time and in the right amount to ensure the safe and effective use of the medication.

Currently, Apelvis is not available in China. Patients in need can only choose to purchase it from overseas or contact regular overseas medical consulting companies. As far as we know, Apelvis has been launched in Hong Kong. The original drug produced by Swiss Novartis Pharmaceuticals is 150mg and 56 capsules, and the price per box is 41,000 yuan. Although the price is higher in Hong Kong, it is also available in the Indian market. The price of 28 tablets of 150mg is 5,080 yuan. In Lucius, Laos, the price has dropped to about 2,500 yuan. If you want to know more about Apelvis, please consult a professional overseas medical consulting company.

Overall, Apelvis provides a new treatment option for patients with certain types of breast cancer, but you need to pay close attention to side effects and follow your doctor's guidance during use.